---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-073372"
form_type: "8-K"
ticker: "REGN"
cik: "0000872589"
company_name: "REGENERON PHARMACEUTICALS, INC."
filed_at: "2024-06-20T23:59:59+00:00"
generated_at: "2026-06-01T03:47:54.815109+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Regeneron shareholders elect directors, approve executive compensation at 2024 annual meeting

## Summary
- Class III directors elected: N.A. Coles, K. Guarini, A.F. Ryan, G.L. Sing; Class II director D.P. Schenkein elected.
- Ratification of PwC as auditor for FY2024: 111.4M for, 5.3M against, 60.6K abstain.
- Advisory vote on executive compensation passed: 106.7M for, 5.6M against, 207.5K abstain, 4.2M broker non-votes.
- Non-binding shareholder proposal requesting simple majority voting approved: 85.9M for, 26.4M against, 188.7K abstain.

## SEC filing metadata
- accession: 0001104659-24-073372
- form_type: 8-K
- ticker: REGN
- cik: 0000872589
- company_name: REGENERON PHARMACEUTICALS, INC.
- filed_at: 2024-06-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/872589/000110465924073372/0001104659-24-073372-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/872589/000110465924073372/tm2417559d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-073372
- JSON: https://secwatch.observer/filing/0001104659-24-073372.json
- Plain text: https://secwatch.observer/filing/0001104659-24-073372.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.